Get the Stockscreener App
7.42
1.16%
0.085
After Hours:
7.42
Health Catalyst Inc stock is traded at $7.42, with a volume of 407.83K.
It is up +1.16% in the last 24 hours and down -6.55% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$7.335
Open:
$7.36
24h Volume:
407.83K
Relative Volume:
0.83
Market Cap:
$451.49M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-4.9467
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+4.80%
1M Performance:
-6.55%
6M Performance:
+20.06%
1Y Performance:
-19.00%
1-Day Range:
$7.18
$7.52
1-Week Range:
$6.72
$7.52
52-Week Range:
$5.42
$11.41
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
7.42 | 451.49M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
213.03 | 34.59B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
67.12 | 11.60B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.22 | 10.31B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
97.47 | 8.45B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Insider Sell: Duncan Gallagher Sells 4,500 Shares of Health Cata - GuruFocus.com
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Director Sells 4,500 Shares of Stock - MarketBeat
Health Catalyst director Gallagher Duncan sells $31,184 in stock By Investing.com - Investing.com Australia
Health Catalyst director Gallagher Duncan sells $31,184 in stock - Investing.com
Health Catalyst, Inc. (NASDAQ:HCAT) Director Duncan Gallagher Sells 4,500 Shares - MarketBeat
Health Catalyst director Gallagher Duncan sells $31,415 in stock By Investing.com - Investing.com Australia
Health Catalyst director Gallagher Duncan sells $31,415 in stock - Investing.com India
Shareholders in Health Catalyst (NASDAQ:HCAT) are in the red if they invested three years ago - Yahoo Finance
How to Take Advantage of moves in (HCAT) - Stock Traders Daily
Meta Platforms Inc (META-Q) QuotePress Release - The Globe and Mail
Health Catalyst (HCAT): Buy, Sell, Or Hold Post Q3 Earnings? - Barchart
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings? - Yahoo Finance
Health Catalyst Inc (HCAT-Q) QuotePress Release - The Globe and Mail
Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Target Price at $11.79 - MarketBeat
Health Catalyst (NASDAQ:HCAT shareholders incur further losses as stock declines 13% this week, taking three-year losses to 81% - Simply Wall St
Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 6,442 Shares of Stock - MarketBeat
Insider Sell: Linda Llewelyn Sells Shares of Health Catalyst Inc (HCAT) - GuruFocus.com
Health Catalyst: Improved Demand Environment Reinforces My Buy Rating (NASDAQ:HCAT) - Seeking Alpha
Healthcare Analytics Market Size, Trends, Growth, - openPR
Health Catalyst leaders share 2025 predictions - Modern Healthcare
Health Catalyst's SWOT analysis: stock outlook amid healthcare IT evolution By Investing.com - Investing.com South Africa
Health Catalyst's SWOT analysis: stock outlook amid healthcare IT evolution - Investing.com
Health Catalyst CFO Jason Alger sells shares worth $163,049 By Investing.com - Investing.com South Africa
Health Catalyst To Participate In Upcoming Investor Conference - Barchart
Health Catalyst CFO Jason Alger sells shares worth $163,049 - Investing.com India
Health Catalyst general counsel Landry Benjamin sells $160,294 in stock By Investing.com - Investing.com Nigeria
Health Catalyst general counsel Landry Benjamin sells $160,294 in stock - Investing.com
Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times
Health Catalyst to Present at J.P. Morgan's 43rd Annual Healthcare Conference - StockTitan
Point72 Asset Management L.P. Increases Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Jacobs Levy Equity Management Inc. Has $913,000 Position in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare - Kilgore News Herald
Health Catalyst COO Daniel LeSueur sells shares worth $175,242 By Investing.com - Investing.com Australia
Health Catalyst COO Daniel LeSueur sells shares worth $175,242 - Investing.com India
Health Catalyst Signs Definitive Agreement to Acquire Top-Rated Cybersecurity Provider, Intraprise Health - Healthcare IT Today
(HCAT) Proactive Strategies - Stock Traders Daily
Health Catalyst chief commercial officer sells $67,073 in stock By Investing.com - Investing.com Canada
Fred Alger Management LLC Makes New $6.86 Million Investment in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Has $1.07 Million Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Millrace Asset Group Inc. Buys New Stake in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat
Health Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Piper Sandler - MarketBeat
Piper Sandler raises Health Catalyst target to $12 on growth outlook - Investing.com Nigeria
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.26%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):